Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220014686 220009285 1.71 87.2 Curative (C) 2015-07-06 2015-07-27 GemCarbo Days 1+8 N N 220035094 PONATINIB
220014693 220009295 1.57 83 Palliative (P) 2017-07-03 2017-07-03 Capecitabine + Oxaliplatin 21day 02 N 220035112 CAPECITABINE + OXALIPLATIN
220014694 220009295 1.68 78 Neo-adjuvant (N) 2014-11-30 2014-12-02 DOXORUBICIN N N 220035112 FCIST
220014695 220009296 null 95.4 Palliative (P) 2014-07-16 2014-07-17 MidAC N null 220035126 MELPHALAN
220014697 220014940 null null Palliative (P) 2015-11-28 2015-11-30 PAD 99 Y 220035134 MELPHALAN
220014698 220014940 null 65.3 Disease modification (D) 2014-09-19 2014-09-19 Methotrexate High Dose (3g/m2) N null 220035134 FEC
220014699 220014940 1.91 29.9 Palliative (P) 2014-01-21 2014-06-26 CTD (Thalidomide 100mg) N N 220035134 DAUNORUBICIN
220014700 220009299 null null Palliative (P) 2016-02-19 2016-03-04 IGEV R N N 220035146 LENALIDOMIDE
220014701 220009303 1.83 99 Curative (C) null 2016-10-14 Cisplatin + Pemetrexed N N 220035152 TRIFLURIDINE + TIPIRACIL
220014702 220009305 1.67 55 Disease modification (D) 2016-05-31 2016-06-30 FIGARO TRIAL 2 N 220035152 CAPECITABINE + IRINOTECAN
220014703 220009307 1.64 68.7 null 2017-05-06 2017-06-05 Ipilimumab 01 N 220035169 BUSULFAN + CYCLOPHOSPHAMIDE
220014704 220014942 1.76 60.8 Curative (C) 2013-04-06 2013-09-07 MidAC Y N 220035181 EVEROLIMUS
220014708 220009310 1.66 105 Curative (C) 2015-12-03 2016-01-14 CETUXIMAB 02 N 220035188 CAPECITABINE
220014709 220014944 1.71 78.6 Curative (C) 2016-06-25 2016-08-04 CAPECITABINE + IRINOTECAN N N 220035189 PEMBROLIZUMAB
220014710 220009316 null 70.5 Curative (C) 2016-05-04 2017-01-15 Cetuximab + FOLFIRI cycle 2 onwards 2 N 220035190 ABIRATERONE
220014711 220014945 null 73.25 Curative (C) 2016-08-02 2017-03-08 BORTEZOMIB + THALIDOMIDE Y N 220035195 EOX
220014713 220009320 1.56 null Palliative (P) null 2015-01-27 FCR 02 null 220035200 UKALL2011
220014714 220009322 0 106.2 Curative (C) 2015-04-03 2015-04-10 Carboplatin + Liposomal Doxorubicin 2 N 220035212 IFOSFAMIDE
220014715 220018158 null 103 Palliative (P) 2014-03-11 2014-03-11 Arsenic trioxide N N 220035219 ETOPOSIDE
220014716 220009325 1.86 0 Curative (C) 2016-03-21 2016-04-27 CAPECITABINE + IRINOTECAN 02 N 220035224 CISPLATIN + FLUOROURACIL
220014717 220009325 1.49 56.2 Curative (C) null 2018-02-01 Vincristine (weekly) 2 Y 220035224 CYTARABINE IT + METHOTREXATE
220014718 220009328 null 17.5 null 2015-08-25 2016-11-27 GCLAC N N 220035231 LENALIDOMIDE
220014719 220009329 null 9.4 Radical (R) 2016-12-14 2016-12-15 BUSULFAN + CYCLO N null 220035232 LENALIDOMIDE
220014720 220009330 null null Curative (C) 2014-12-20 2014-12-26 DHAP N null 220035241 EPIRUBICIN
220014721 220009330 null 65 Disease modification (D) 2013-04-20 2013-04-30 DOCETAXEL + GEMCITABINE N N 220035241 LI-1 TRIAL
220014722 220019966 null null null 2015-09-13 2015-09-20 CHOP R - 21 days null null 220035243 CHLVPP
220014723 220014952 1.77 13 Disease modification (D) 2016-08-26 2017-06-21 CARBOPLATIN + RT 2 N 220035265 DABRAFENIB + TRAMETINIB
220014724 220009333 1.66 78.4 Palliative (P) 2013-09-19 2013-09-19 Capecitabine (21 day) + Irinotecan N N 220035268 CLADRIBINE + CYTARABINE + DAUNORUBICIN
220014725 220009334 null null null 2016-03-14 2016-03-19 MELPHALAN null N 220035271 UKALL2011
220014726 220014953 1.73 87.1 Curative (C) 2016-02-05 2016-02-05 PEMBROLIZUMAB N N 220035271 BUSULPHAN
220014727 220009335 null null null 2013-12-13 2014-01-05 CVAD Y N 220035279 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
220014728 220014954 1.64 76 Palliative (P) 2016-08-16 2016-08-27 PEMBROLIZUMAB 01 N 220035292 TEMOZOLOMIDE + RT
220014729 220009338 1.72 59 Disease modification (D) 2013-12-17 2013-12-29 PEMBROLIZUMAB N N 220035295 TRASTUZUMAB
220014730 220014955 1.83 101.6 Palliative (P) 2014-02-10 2014-02-13 Sunitinib N N 220035295 LIPOSOMAL CYTARABINE
220014731 220014956 1.75 55 Disease modification (D) 2015-07-23 2015-07-23 Cisplatin + Pemetrexed 02 N 220035304 IPILIMUMAB + NIVOLUMAB
220014732 220014956 1.67 78.4 Palliative (P) 2014-11-05 2014-11-13 DABRAFENIB 01 N 220035304 CYTARABINE + MITOXANTRONE
220014733 220014956 null null Adjuvant (A) 2018-06-13 2018-06-13 R GCVP 99 N 220035304 GEMCITABINE
220014734 220021920 1.57 63 Palliative (P) 2018-03-13 2018-03-13 Melphalan IV High dose N N 220035316 CHOP R
220014735 220022274 1.53 64.1 Palliative (P) 2013-03-18 2013-03-19 MELPHALAN null N 220035320 UKALL 2011
220014736 220009342 1.7 69.6 Palliative (P) null 2015-08-12 CISPLATIN + FLUOROURACIL N N 220035326 POMALIDOMIDE
220014737 220009343 1.77 127 Palliative (P) 2017-10-19 2017-10-19 MERCAPTOPURINE + METHOTREXATE 02 N 220035327 CHOP R
220014738 220009344 null null Curative (C) 2014-12-12 2015-01-21 DAUNORUBICIN N null 220035327 TRASTUZUMAB
220014739 220009347 1.63 null null 2013-08-21 2013-08-21 Carboplatin + Liposomal Doxorubicin N N 220035332 MIDAC
220014740 220009348 1.8 83.2 Curative (C) 2017-12-29 2017-12-29 CISPLATIN + FLUOROURACIL N N 220035332 VIDE
220014741 220009349 1.8 102.2 Disease modification (D) 2015-02-14 2015-02-14 Carboplatin AUC 6 - 10 N N 220035338 BEVACIZUMAB
220014742 220009350 1.79 118.5 Palliative (P) 2014-11-21 2014-11-21 Gemcitabine 1000mg/m2 D1 8 15 N N 220035340 TRASTUZUMAB
220014743 220014963 1.56 78.4 Not known (9) 2013-03-14 2013-04-03 OSIMERTINIB 02 N 220035347 IPILIMUMAB
220014744 220009353 1.72 96.7 Palliative (P) 2015-12-05 2015-12-05 Capecitabine 02 N 220035350 ALL MAINTENANCE
220014747 220009357 1.75 72.5 Curative (C) 2015-02-06 2015-02-13 CAPECITABINE + GEMCITABINE 2 N 220035373 BEVACIZUMAB
220014748 220009361 1.8 74 Disease modification (D) 2018-06-26 2018-07-14 Bendamustine + prednisolone N N 220035373 EPIRUBICIN